Berkshire Asset Management LLC Cumberland Pharmaceuticals Inc Transaction History

Berkshire Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.93 - $3.03 $13,330 - $20,928	6,907 Added 3.79%	189,048 $392,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $6.94 $13,103 - $41,334	5,956 Added 3.38%	182,141 $851,000
Q3 2021 Nov 15, 2021	BUY	$2.66 - $3.45 $14,244 - $18,474	5,355 Added 3.13%	176,185 $472,000
Q2 2021 Aug 16, 2021	BUY	$2.59 - $3.3 $13,817 - $17,605	5,335 Added 3.22%	170,830 $486,000
Q4 2020 Feb 16, 2021	BUY	$2.9 - $3.3 $479,935 - $546,133	165,495 New	165,495 $488,000
Q2 2020 Aug 12, 2020	SELL	$3.17 - $4.01 $521,449 - $659,624	-164,495 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$3.45 - $5.33 $567,507 - $876,758	164,495 New	164,495 $597,000

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Berkshire Asset Management LLC with notifications on news.